People · Operator

Donald R. Schemel

Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology

1
Companies
1
Filings
$8.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Sun BioPharma, Inc.BiotechnologySeed$8.0M$52.2M2015
Operator network

Donald R. Schemel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

DAVID B. KAYSEN · 4 companies · 1 sharedDAVID B. KAYSENThomas X. Neenan · 3 companies · 1 sharedThomas X. NeenanD. Robert Schemel · 2 companies · 1 sharedD. Robert SchemelJeffrey R. Harder · 2 companies · 1 sharedJeffrey R. HarderMichael T. Cullen · 2 companies · 1 sharedMichael T. CullenPAUL W. SCHAFFER · 2 companies · 1 sharedPAUL W. SCHAFFERChristopher R. Johnson · 1 companies · 1 sharedChristopher R. Jo…Clifford F. McCurdy, III · 1 companies · 1 sharedClifford F. McCur…Daniel E. Ryweck · 1 companies · 1 sharedDaniel E. RyweckDouglas M. Polinsky · 1 companies · 1 sharedDouglas M. Polins…Paul M. Herron · 1 companies · 1 sharedPaul M. HerronRandall L. Johnson · 1 companies · 1 sharedRandall L. JohnsonRyan R. Gilbertson · 1 companies · 1 sharedRyan R. GilbertsonSuzanne X. Gagnon · 1 companies · 1 sharedSuzanne X. GagnonSun BioPharma, Inc. · $8.0M raisedSun BioPharma, Inc.Donald R. SchemelDS
Donald R. Schemel Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Donald R. Schemel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
DAVID B. KAYSEN14
Thomas X. Neenan13
D. Robert Schemel12
Michael T. Cullen12
Jeffrey R. Harder12
PAUL W. SCHAFFER12
Christopher R. Johnson11
Clifford F. McCurdy, III11
Suzanne X. Gagnon11
Daniel E. Ryweck11
Randall L. Johnson11
Douglas M. Polinsky11
Ryan R. Gilbertson11
Paul M. Herron11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.